DG
BSX icon

DMC Group’s Boston Scientific BSX Stock Holding History

DMC Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,721
Closed -$484K – 131
2026
Q1 		$484K Sell
7,721
-581
-7% -$46.5K 0.33% 86
2025
Q4 		$792K Buy
8,302
+751
+10% +$73.6K 0.53% 57
2025
Q3 		$737K Buy
7,551
+33
+0.4% +$3.42K 0.51% 62
2025
Q2 		$808K Sell
7,518
-318
-4% -$32.2K 0.63% 49
2025
Q1 		$790K Sell
7,836
-63
-0.8% -$6.34K 0.64% 49
2024
Q4 		$706K Buy
7,899
+947
+14% +$83.4K 0.57% 53
2024
Q3 		$583K Buy
6,952
+1,034
+17% +$81.5K 0.47% 74
2024
Q2 		$456K Buy
5,918
+691
+13% +$50.6K 0.39% 80
2024
Q1 		$358K Buy
5,227
+312
+6% +$20.1K 0.31% 93
2023
Q4 		$284K Buy
4,915
+868
+21% +$46.3K 0.27% 103
2023
Q3 		$214K Buy
+4,047
New +$212K 0.2% 114

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DMC Group's BSX Position: Q2 2026 in Review

DMC Group sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 7,721 shares — an estimated $484K sold.

DMC Group first reported a position in BSX in Q3 2023 and held it in 11 quarters. The position peaked at $808K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • DMC Group reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • DMC Group sold 7,721 Boston Scientific shares in Q2 2026, an estimated $484K.
  • DMC Group first reported a position in Boston Scientific in Q3 2023 and held it in 11 quarters.
  • DMC Group's Boston Scientific position peaked at $808K in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on DMC Group's 13F filing for Q2 2026, filed 28 Jul 2026.